Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Anupam Rasayan India Ltd

NSE: ANURAS · BSE: 543275 · Chemicals & Petrochemicals · 60 announcements

Anupam Rasayan India Ltd news stories on ALFA NewsRead the news →
Share price
₹1,164.00
Market cap
₹13,252 Cr
Revenue (annual)
₹2,365 Cr
Net profit (annual)
₹170.1 Cr
P/E (TTM)
75.8×Sector 37.2×
Promoter holding
59.07%+0.00% QoQ
FII holding
7.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21:37 IST BSE
Acquisition

Anupam Rasayan India Acquisition Worth ₹60.88 Cr

Anupam Rasayan India Ltd. acquired 2,60,065 shares in Tanfac Industries Ltd. for ₹60.88 Crore via a preferential issue to increase its stake in the subsidiary.

Value
₹60.88 Cr
16:56 IST NSE
Acquisition

Anupam Rasayan India Acquisition Worth ₹1,370 Cr

Anupam Rasayan will acquire a controlling 43.30% stake in Bliss GVS Pharma for ₹1369.51 Crore. This strategic acquisition integrates pharmaceutical operations and unlocks operational synergies.

Value
₹1,370 Cr
Execution
Expected to be completed within 6 months.
20:59 IST BSE
Acquisition

Anupam Rasayan India Acquisition Worth ₹300 Cr

Anupam Rasayan announced a ₹300 Crore acquisition of a 43.3-48.2% stake in Bliss GVS Pharma Limited. The deal integrates its specialty chemical capabilities with pharmaceutical formulations.

Value
₹300.0 Cr
19:36 IST NSE
Acquisition

Anupam Rasayan India Acquisition Worth ₹2,250 Cr

Anupam Rasayan will acquire up to 74.20% of Bliss GVS Pharma for approximately ₹2250.36 Crore. This strategic acquisition strengthens the company's presence across the pharmaceutical value chain.

Value
₹2,250 Cr
Execution
6 months